期刊文献+

RP-HPLC法测定重组人胰高血糖素类多肽-1(7-36)原料及其制剂的肽含量和有关物质 被引量:2

RP -HPLC Analysis of Recombinant Human Glucagon -like Peptide -1(7-36) and Its Related Substances
下载PDF
导出
摘要 目的:建立重组人胰高血糖素类多肽-1(7-36)[rhGIP-1(7-36)]原料及制剂的肽含量和有关物质的RP-HPLC测定方法。方法:采用ODS柱(250 mm×4.6 mm,5μm),以0.2 mol·L-1硫酸钠缓冲液(用乙醇胺调节pH至2.3)-乙腈(82:18)为流动相A,50%乙腈为流动相B,调整流动相的比例[A-B(55:45)]使主峰的保留时间在20-25 min,流速为1.0 mL·min-1,检测波长214 nm,柱温为45℃。结果:线性范围为0.6-18.6μg,制剂平均回收率为96.01%,原料和制剂精密度试验RSD分别为0.15%和0.25%,最低检测限6.25 ng。结论:本方法可用于rhGLP-1(7-36)原料及其制剂的肽含量和有关物质的测定,具有准确、简便、快速、灵敏的特点。 Objective: To establish a RP - HPLC method for determination of recombinant human glucagon - like peptide -1(7-36 )[rhGLP-1(7-36)],content of rhGLP - 1 (7 - 36 ) for injection and related substances. Methods: A ODS column(250 mm×4. 6 mm,5μm) was used,the mobile phase A were 0. 2 mol·L-1 sodium sul-fate buffer(adjusted to pH 2. 3 with ethanolamine) - acetonitrile(82: 18) and mobile phase B consisted of 50% acetonitrile, adjusted the ratio of mobile phase to keep the retention time of rhGLP -1(7-36) and related compounds between 20 to 25 minutes [A-B( 55: 45)] , the flow rate was 1 mL·min-1 and the detection wavelength was 214 nm,the column temperature was 45℃. Results:The calibration curves were linear in the range of 0. 6-18. 6μg. The recovery of rhGLP-1 (7-36) for injection was 96.01 % , the LOD was 6. 25 ng. Conclusion: The method can be used analysis of rhGLP -1(7 -36)and its related substances,it is accurate,simple and quick.
出处 《药物分析杂志》 CAS CSCD 北大核心 2004年第2期187-189,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 RP-HPLC法 重组人胰高血糖素类多肽-1(7-36) 有关物质 含量测定 色谱条件 多肽 RP-HPLC, recombinant human glucagon-like peptide -1(7-36) [rhGLP-1(7-36)], assay, related substance
  • 相关文献

参考文献4

  • 1王军志主编..生物技术药物研究开发和质量控制[M].北京:科学出版社,2002:809.
  • 2Yoshiaki Nabuchi, Eri Fujiwara, Hitoshi Kuboniwa, et al. The stability and degradation pathway of recombinant human parathyroid hormone:Deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues. Pharm Res, 1997,14 ( 12 ) : 1685. 被引量:1
  • 3.中国药典.二部[M].,.929. 被引量:7
  • 4施蕴渝 饶子和译.蛋白质结构分析:制备、鉴定与微量测序[M].北京:科学出版社,2002.50. 被引量:1

共引文献6

同被引文献21

  • 1乐嘉静,李湛君,邱财荣,宫泽辉,徐康森.重组人胰高血糖素类多肽-1(7-36)对化学致糖尿病模型动物的降血糖作用[J].中国药理学通报,2004,20(10):1171-1173. 被引量:10
  • 2廖海明,吕英英,盛龙生,徐康森.RP-HPLC法分析重组人胰高血糖素类多肽-1(7-36)肽图谱[J].药物分析杂志,2005,25(1):24-26. 被引量:4
  • 3郑专杰,方翼,王睿.ELISA试剂盒方法测定重组人胰高血糖素类多肽-1(7-36)浓度[J].中国临床药理学与治疗学,2006,11(4):444-447. 被引量:3
  • 4Drucker DJ. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes[J]. Curt Pharm Des,2001; 7:1399-412 被引量:1
  • 5Schirra J, Leicht P, Hildebrand P, Beglinger C, Arnold R,Goke B, et al. Mechanism of the antidiabefic action of subcutaneous glucagons-like peptide-1 (7-36)amide in non-insulin dependent diabetes mellitus[J]. J Endocrinol, 1998; 156:177 -86 被引量:1
  • 6Hoist, Jens J. Glucagon-like peptide-1:physiology and therapeutic potential[J]. Curr Opin Endocrinol Diab,2005; 12: 56 -62 被引量:1
  • 7Hedetofi C, Sheikh SP, Larsen S, Hoist JJ. Effect of Glucagon-Like Peptide 1 (7-36)Amide in Insulin-Treated Patients with Diabetes MeUitus Secondary to Chronic Pancreatitis[J]. Pancreas,2000;20:25 - 31 被引量:1
  • 8Peffetti R, Merkel P. Glucagon-like peptide- 1 : a major regulator of pancreatic β-cell function[J]. Eur of Endocrinol,2000; 143:717 - 25 被引量:1
  • 9Shyangdan DS, Royle P, Clar C, et al. Glucagon- like peptide analogues for type 2 diabetes mellitus [J].Cochrane Database Syst Rev, 2011,5(10): CD006423. 被引量:1
  • 10Eng J, Kleinman WA, Singh L, et al. Isolation and characterization of exendin-4, an exendin-3 ana- logue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas [J]. J Biol Chem, 1992, 267(11) : 7402-7405. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部